Biohaven presentation at aan showed decreased opioid use in migraine patients following nurtec® odt therapy: a real-world administrative claims analysis

Longitudinal medical and prescription claims were used to assess opioid prescriptions and mme's dispensed amongst migraine patients nine months prior to and nine months following nurtec® odt initiation.   among the 14,019 with migraine who used opioids prior to initiating treatment with nurtec odt, approximately 41% had no opioid rx fills in the 9 months following initiation.
BHVN Ratings Summary
BHVN Quant Ranking